2023-03-12 18:35:00 ET
- Spero Therapeutics ( NASDAQ: SPRO ) is scheduled to announce Q4 earnings results on Monday, March 13, after market close.
- The consensus EPS Estimate is -$0.34 (+62.2% Y/Y) and the consensus Revenue Estimate is $22.87M (+734.7% Y/Y).
- Over the last 1 year, SPRO has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
For further details see:
Spero Therapeutics Q4 2022 Earnings Preview